Tranexamic acid Lysteda
Jeneng umum: Tranexamic Acid (Lysteda)
Kelas obat:
Aneka modifikasi koagulasi
Panganggone Tranexamic acid Lysteda
Asam traneksamat minangka wujud asam amino (protein) sing diarani lisin. Asam traneksamat nyegah enzim ing awak ngrusak gumpalan getih.
Lysteda digunakake kanggo nambani pendarahan menstruasi sing abot. Obat iki ora bakal nambani sindrom pramenstruasi (PMS).
Asam traneksamat uga bisa digunakake kanggo tujuan sing ora kadhaptar ing pandhuan pengobatan iki.
Tranexamic acid Lysteda efek sisih
Entuk bantuan medis darurat yen sampeyan duwe salah siji saka tandha reaksi alergi iki: gatal-gatal; kangelan ambegan; bengkak ing pasuryan, lambe, ilat, utawa tenggorokan.
Stop njupuk Lysteda lan langsung hubungi dhokter yen sampeyan duwe efek samping sing serius kayata:
Efek sisih sing kurang serius kalebu:
Iki dudu dhaptar lengkap efek samping lan liya-liyane bisa uga. dumadi. Telpon dhokter kanggo saran medis babagan efek samping. Sampeyan bisa nglaporake efek samping menyang FDA ing 1-800-FDA-1088.
Sadurunge njupuk Tranexamic acid Lysteda
Sampeyan ora kudu njupuk Lysteda yen sampeyan alergi marang asam traneksamat, utawa yen sampeyan duwe:
Kanggo mesthekake sampeyan bisa njupuk Lysteda kanthi aman, hubungi dhokter yen sampeyan duwe kondisi liyane:
Ora dingerteni manawa asam traneksamat bakal ngrusak bayi sing durung lair. Marang dhokter sampeyan yen sampeyan lagi ngandhut utawa arep ngandhut nalika nggunakake obat iki.
Asam traneksamat bisa mlebu ing ASI lan bisa ngrusak bayi sing lagi nyusoni. Aja nggunakake obat iki tanpa ngandhani dhokter yen sampeyan lagi nyusoni bayi.
Aja menehi obat iki marang sapa wae sing umure kurang saka 18 taun tanpa saran dhokter.
Aja nuduhake Lysteda karo wong liya, sanajan dheweke duwe gejala sing padha karo sampeyan.
Related obat
- Advate
- Adynovate
- Adynovate recombinant
- Afstyla
- Afstyla recombinant
- Agrylin
- Alphanate
- Alphanine SD
- Alprolix
- Alprolix (Factor ix fc fusion protein recombinant Intravenous)
- Altuviiio
- Altuviiio (Antihemophilic factor (recombinant), fc-vwf-xten fusion protein-ehtl Intravenous)
- Altuviiio (Antihemophilic factor Intravenous)
- Amicar
- Amicar (Aminocaproic acid Intravenous)
- Amicar (Aminocaproic acid Oral)
- Aminocaproic acid
- Aminocaproic acid (Intravenous)
- Aminocaproic acid (Oral)
- Anagrelide
- Anti-inhibitor coagulant complex
- Antihemophilic and von Willebrand factor complex
- Antihemophilic factor
- Antihemophilic factor (recombinant) pegylated-aucl
- Antihemophilic factor (recombinant) porcine sequence
- Antihemophilic factor (recombinant), fc-vwf-xten fusion protein-ehtl
- Antihemophilic factor (recombinant), glycopegylated-exei
- Antihemophilic factor human
- Antihemophilic factor recombinant
- Antihemophilic factor viii and von willebrand factor
- Artiss
- Artiss Duo Set
- Artiss Duploject
- Autoplex T
- Coagadex
- Coagulation factor IX
- Coagulation factor ix recombinant
- Coagulation factor ix recombinant, glycopegylated
- Coagulation factor viia
- Coagulation factor VIIa injection
- Coagulation factor viia-jncw
- Coagulation factor X
- Corifact
- Cyklokapron
- Bebulin VH
- BeneFIX
- Benefix (Coagulation factor ix recombinant Intravenous)
- Ceprotin
- Defibrotide
- Defitelio
- Eloctate
- Eloctate with Fc Fusion Protein recombinant
- Emicizumab
- Emicizumab-kxwh
- Esperoct (Antihemophilic factor (recombinant), glycopegylated-exei Intravenous)
- Esperoct (Antihemophilic factor Intravenous)
- Esperoct recombinant
- Evarrest
- Factor ix albumin fusion protein recombinant
- Factor IX complex
- Factor ix fc fusion protein recombinant
- Factor x human
- Factor XIII
- Feiba VH Immuno
- Feiba-VH
- Fibrin sealant topical
- Fibrinogen
- Fibrinogen and thrombin, human
- Fibrinogen/aprotinin and thrombin/calcium chloride
- Fostamatinib
- Fostamatinib disodium
- Helixate FS
- Helixate FS recombinant
- Hemlibra
- Hemofil-M
- Hemofil-M human
- Humate-P
- Hyate:C
- Idelvion
- Idelvion (Factor ix albumin fusion protein recombinant Intravenous)
- Ixinity
- Ixinity (Coagulation factor ix recombinant Intravenous)
- Jivi (Antihemophilic factor (recombinant) pegylated-aucl Intravenous)
- Jivi (Antihemophilic factor Intravenous)
- Jivi recombinant
- Koate DVI
- Koate-DVI human
- Kogenate FS
- Kogenate FS recombinant
- Kogenate FS with Adapter recombinant
- Kovaltry recombinant
- Lysteda
- Monoclate-P human
- Mononine
- Novoeight recombinant
- Novoseven
- NovoSeven RT
- NovoSeven RT with MixPro injection
- Nuwiq recombinant
- Obizur (Antihemophilic factor (recombinant) porcine sequence Intravenous)
- Obizur (Antihemophilic factor Intravenous)
- Pentopak
- Pentoxifylline
- Pentoxil
- Protein c, human
- Raplixa
- Rebinyn
- Rebinyn (Coagulation factor ix recombinant, glycopegylated Intravenous)
- Recombinate recombinant
- RiaSTAP
- Rixubis
- Rixubis (Coagulation factor ix recombinant Intravenous)
- Roctavian
- Tachosil
- Tavalisse
- Thrombin human, recombinant
- Tisseel
- Tisseel Duploject Kit
- Tisseel Valupak Kit
- Tranexamic acid
- Tranexamic acid (Intravenous)
- Tranexamic acid (Oral)
- Tranexamic acid Lysteda
- Trental
- Tretten
- Valoctocogene roxaparvovec-rvox
- Von Willebrand factor recombinant
- Vonvendi
- Wilate
- Xyntha
Carane nggunakake Tranexamic acid Lysteda
Dosis Dewasa Biasa kanggo Perdarahan:
Dosis awal: 10 mg/kg intravena, sanalika sadurunge ekstraksi dental Dosis pangopènan: 10 mg/kg intravena telu nganti patang dina. terapi: 2 nganti 8 dinaKomentar: Infuse ora luwih saka 1 mL/menit kanggo ngindhari hipotensi.Panganggone: Panggunaan jangka pendek ing pasien hemofilia kanggo nyuda utawa nyegah pendarahan lan nyuda kabutuhan terapi panggantos sajrone lan sawise cabut waos. p>
Dosis Dewasa Biasa kanggo Gangguan Menstruasi:
Dosis: 1300 mg (loro tablet 650 mg) oral kaping telu dina (3900 mg / dina) sajrone menstruasi Durasi. : Maksimal 5 dinaPanggunakake: Kanggo ngobati perdarahan menstruasi sing akeh siklus
Dosis Pediatrik Biasa kanggo Perdarahan:
Dosis awal: 10 mg/kg intravena, sanalika sadurunge ekstraksi dental Dosis pangopènan: 10 mg / kg intravena kaping telu nganti kaping papat saben dina. -Infuse ora luwih saka 1 mL/menit kanggo ngindhari hipotensi.Panganggone: Panggunaan jangka pendek ing pasien hemofilia kanggo nyuda utawa nyegah pendarahan lan nyuda kabutuhan terapi pengganti nalika cabut waos.
Biasane Dosis Pediatrik kanggo Gangguan Menstruasi:
Wanita sawise menstruasi: Dosis: 1300 mg (loro tablet 650 mg) oral kaping telu dina (3900 mg / dina) sajrone menstruasi Durasi: Maksimal 5 dina Gunakake: Kanggo perawatan pendarahan menstruasi sing abot ing wanita sawise menstruasi
Pènget
Sampeyan ora kudu nggunakake obat iki yen sampeyan alergi marang asam traneksamat, yen sampeyan duwe masalah karo pembuluh getih ing mripat, utawa yen sampeyan tau ngalami stroke, gumpalan getih, utawa getihen ing otak. .
Sadurunge nggunakake asam traneksamat, takon dhokter sampeyan yen sampeyan duwe penyakit ginjel, leukemia, riwayat endometriosis, utawa yen siklus menstruasi kurang saka 21 dina utawa luwih saka 35 dina.
Aja miwiti njupuk Lysteda nganti haid wis diwiwiti. Aja njupuk luwih saka 5 dina saurutan. Dhiskusi karo dhokter yen gejala sampeyan ora saya apik sawise 2 siklus perawatan.
Aja njupuk luwih saka 6 tablet sajrone wektu 24 jam.
Gunakake wangun penghalang lair. kontrol (kayata kondom utawa diafragma karo spermisida). Kontrasepsi hormonal (kayata pil KB, injeksi, implan, tambalan kulit, lan cincin vagina) bisa nambah risiko stroke, bekuan getih, utawa serangan jantung yen digunakake bebarengan karo Lysteda.
Aja nuduhake Lysteda karo wong liya, sanajan dheweke duwe gejala sing padha.
Apa obatan liyane bakal mengaruhi Tranexamic acid Lysteda
Marang dhokter sampeyan babagan kabeh obat liyane sing sampeyan gunakake, utamane:
Iki dhaftar ora lengkap lan obatan liyane bisa sesambungan karo Lysteda. Marang dhokter sampeyan babagan kabeh obat sing sampeyan gunakake. Iki kalebu resep, over-the-counter, vitamin, lan produk herbal. Aja miwiti obat anyar tanpa ngandhani dhokter sampeyan.
Disclaimer
Kabeh upaya wis ditindakake kanggo mesthekake yen informasi sing diwenehake dening Drugslib.com akurat, nganti -tanggal, lan lengkap, nanging ora njamin kanggo efek sing. Informasi obat sing ana ing kene bisa uga sensitif wektu. Informasi Drugslib.com wis diklumpukake kanggo digunakake dening praktisi kesehatan lan konsumen ing Amerika Serikat lan mulane Drugslib.com ora njamin sing nggunakake njaba Amerika Serikat cocok, kajaba khusus dituduhake digunakake. Informasi obat Drugslib.com ora nyetujoni obat, diagnosa pasien utawa menehi rekomendasi terapi. Informasi obat Drugslib.com minangka sumber informasi sing dirancang kanggo mbantu praktisi kesehatan sing dilisensi kanggo ngrawat pasien lan / utawa nglayani konsumen sing ndeleng layanan iki minangka tambahan, lan dudu pengganti, keahlian, katrampilan, kawruh lan pertimbangan babagan perawatan kesehatan. praktisi.
Ora ana bebaya kanggo kombinasi obat utawa obat sing diwenehake kanthi cara apa wae kudu ditafsirake kanggo nuduhake yen obat utawa kombinasi obat kasebut aman, efektif utawa cocok kanggo pasien tartamtu. Drugslib.com ora nanggung tanggung jawab kanggo aspek kesehatan apa wae sing ditindakake kanthi bantuan informasi sing diwenehake Drugslib.com. Informasi sing ana ing kene ora dimaksudake kanggo nyakup kabeh panggunaan, pituduh, pancegahan, bebaya, interaksi obat, reaksi alergi, utawa efek samping. Yen sampeyan duwe pitakon babagan obat sing sampeyan gunakake, takon dhokter, perawat utawa apoteker.
Tembung kunci populer
- metformin obat apa
- alahan panjang
- glimepiride obat apa
- takikardia adalah
- erau ernie
- pradiabetes
- besar88
- atrofi adalah
- kutu anjing
- trakeostomi
- mayzent pi
- enbrel auto injector not working
- enbrel interactions
- lenvima life expectancy
- leqvio pi
- what is lenvima
- lenvima pi
- empagliflozin-linagliptin
- encourage foundation for enbrel
- qulipta drug interactions